Insider trades

Pamela J. Cramer, Chief Officer of Rhythm Pharmaceuticals RYTM, has filed 0 purchases and 31 sales on the open market. Over the past 12 months that comes to a net sale of $3M. The latest trade was on 02/11.

Pamela J. Cramer

Chief Human Resources Officer
First filing
23/02/03
Trades
96 trades
Buys / sales
0 / 31
12-month net buying
−$3M
Last trade
02/11

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan25/12/1125/12/153,350 sh$111.00$371,850−13.9%
Open-market sale10b5-1 plan25/11/2025/11/243,350 sh$105.00$351,750−13.9%
RYTM
Open-market sale10b5-1 plan25/11/07–25/11/1025/11/1222,866 sh2 trades$99.00avg.$2,263,765.82−52.3%
Open-market sale10b5-1 plan25/07/2925/07/291,520 sh$85.93$130,613.6−6.8%
RYTM
Open-market sale10b5-1 plan25/07/0925/07/1115,572 sh3 trades$77.13avg.$1,201,038.14−44.8%
Open-market sale10b5-1 plan25/06/0625/06/107,031 sh$68.05$478,459.55−26.8%
Open-market sale10b5-1 plan25/04/2925/05/017,031 sh$65.09$457,647.79−26.8%
RYTM
Open-market sale10b5-1 plan25/04/0825/04/1020,760 sh4 trades$60.14avg.$1,248,514.8−51.9%
Open-market sale10b5-1 plan25/02/1925/02/19982 sh$57.22$56,190.04−4.9%
RYTM
Open-market sale10b5-1 plan25/02/1125/02/11701 sh2 trades$57.51avg.$40,314.6−4.0%
Open-market sale25/02/0425/02/04902 sh$59.43$53,605.86−5.6%
RYTM
Open-market sale10b5-1 plan24/11/06–24/11/0724/11/089,375 sh2 trades$62.50avg.$585,940−41.0%
Open-market sale10b5-1 plan24/09/0924/09/114,099 sh$50.03$205,072.97−23.3%
Open-market sale10b5-1 plan24/08/2624/08/283,200 sh$50.01$160,032−19.2%
RYTM
Open-market sale10b5-1 plan24/08/0924/08/1349,006 sh2 trades$45.15avg.$2,212,671.74−78.4%
Open-market sale10b5-1 plan24/07/2924/07/301,395 sh$49.06$68,438.7−4.2%
Open-market sale24/03/1924/03/1915,515 sh$39.22$608,498.3−34.1%
Open-market sale24/02/1224/02/13696 sh$51.38$35,760.48−5.6%
Open-market sale24/02/0124/02/05946 sh$45.06$42,626.76−8.5%
Open-market sale10b5-1 plan23/07/2623/07/28930 sh$17.64$16,405.2−9.9%